HDX WILL (Co., Ltd.) is a well-known oral imaging equipment manufacturing and R&D enterprise in South Korea. The CTO of its R&D center, Dr. Ding Hong, graduated from the Korea Academy of Science and Technology and won the championship in the 2009 International Medical Magnetic Reconstruction Association Reconstruction Challenge.

Dr. Ding Hong now leads a professional research team composed of more than 40 people with master's and doctorate degrees, and has been committed to the research of oral imaging, hoping to provide more professional and high-quality imaging services for diagnosis. The CBCT low-dose scanning mode developed and applied by his team is the first local company in South Korea to achieve high-quality image quality while reducing radiation dose by 1/3.

As of October 2017, HDX WILL (Co., Ltd.) has reached an annual turnover of 36 billion won (approximately 200 million yuan). And achieved the first place in market share in South Korea.

In the future, HDX WILL (Co., Ltd.) will adhere to the concept of service first to better serve the dental industry.